CR-3294

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCR-3294

Drug Alias NameCR-3294

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMatrix metalloproteinase inhibitorsNitric oxide synthase, inducible inhibitors

TargetsMatrix metalloproteinaseNitric oxide synthase, inducible

Therapy Area/IndicationsDiarrheaInflammatory Bowel Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesRottapharm

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesRottapharm

Active IndicationsN/A

Inactive IndicationsDiarrheaInflammatory Bowel Diseases

ATC CodeN/A